通过针对微小残留病灶改变卵巢癌护理。
Transforming ovarian cancer care by targeting minimal residual disease.
发表日期：2023 Nov 10
作者：
Amir A Jazaeri, Rachel Grisham, Anne Knisely, Stefani Spranger, Dmitriy Zamarin, R Tyler Hillman, Barrett C Lawson, Kathleen H Burns, Sanghoon Lee, Shannon N Westin, Enrico Moiso, Marc J Williams, Neelkanth M Bardhan, Thomas Pisanic, Ursula Matulonis, Britta Weigelt, IeMing Shih, Panagiotis A Konstantinopoulos, Stephanie Gaillard, Linghua Wang, Carol Aghajanian, Alan D D'Andrea, Paula Hammond, Sohrab Shah, Kai W Wucherpfennig, Karen H Lu
来源：
Burns & Trauma
摘要：
过去几十年来，晚期卵巢癌患者的一线治疗和最终治愈率几乎没有变化。在此，我们概述了一种多学科方法，旨在通过关注人们知之甚少的卵巢癌微小残留病阶段（导致最终无法治愈的复发）来获得新颖的治疗见解。版权所有 © 2023 Elsevier Inc. 保留所有权利。
Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.Copyright © 2023 Elsevier Inc. All rights reserved.